Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity (Q31402230)

2 July 2017

title

Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity (English)

1 reference

2 July 2017

0 references

1 reference

1 reference

Van Kampen JM

1 reference

2 July 2017

McGeer EG

series ordinal

1 reference

2 July 2017

Stoessl AJ

series ordinal

1 reference

2 July 2017

publication date

1 September 2000

1 reference

2 July 2017

1 reference

2 July 2017

1 reference

2 July 2017

1 reference

2 July 2017

page(s)

171-178

1 reference

Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.

2 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Depletion of striatal dopamine transporter does not affect psychostimulant-induced locomotor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

MPP+ toxicity and plasma membrane dopamine transporter: study using cell lines expressing the wild-type and mutant rat dopamine transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Species differences in functions of dopamine transporter: paucity of MPP+ uptake and cocaine binding in bovine dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Evidence for carrier-mediated efflux of dopamine from corpus striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

The molecular cloning and expression of a human synaptic vesicle amine transporter that suppresses MPP+ toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Immunochemical analysis of dopamine transporter protein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

ANTISENSE oligonucleotides: a new tool in neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

A 40-nucleotide repeat polymorphism in the human dopamine transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Amphetamine: effects on catecholamine systems and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Parkinson's disease: neurotransmitter and neurotoxin receptors and their genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Recent biochemical studies of the dopamine transporter — A CNS drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Association of a polymorphism in the dopamine-transporter gene with parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Dopamine-induced apoptosis in human neuronal cells: inhibition by nucleic acids antisense to the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

Dopamine transporter cysteine mutants: second extracellular loop cysteines are required for transporter expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820000901%2937%3A3%3C171%3A%3AAID-SYN1%3E3.0.CO%3B2-R

10.1002/1098-2396(20000901)37:3<171::AID-SYN1>3.0.CO;2-R

21 January 2018

Identifiers

DOI

1 reference

2 July 2017

1 reference